Medical News Summary: New drug approved for treatment of pain associated with diabetic neuropathy
About: New drug approved for treatment of pain associated with diabetic neuropathy
Date: 7 January 2005
Source: Reuters Health
Medical News Summary (summary of medical news story as reported by Reuters Health): Pfizer’s new drug, Lyrica (pregabalin) was last week approved by the FDA to treat pain associated with diabetic neuropathy. The drug claims to be well-tolerated by patients and is effective in reducing pain as well as the added bonus of improving sleep. The benefits were noticed within one week of commencing treatment during trials. Side effects were mostly mild cases of dizziness and sleepiness.
URL: http://www.reuters.co.uk/newsArticle.jhtml?type=healthNews&storyID=7270007
Related Disease Topics: Diabetic neuropathy, Diabetes, Insomnia, Dizziness, Sleepiness
Related Symptom Topics: Pain
Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
- Type 1 diabetes
- Type 2 diabetes
- Medication
- medication and diabetic neuropathy
- medication and diabetes
- medication and insomnia
- medication and dizziness
- medication and sleepiness
- medication and pain
- Research
- research and diabetic neuropathy
- research and diabetes
- research and insomnia
- Research and dizziness
- Research and sleepiness
- research and pain
- Side effect
- Side effect and dizziness
- Side effect and sleepiness
- cause of sleepiness
- cause of dizziness
- cause of pain
Medical Tools & Articles:
Next articles:
Medical Articles: